Evidence of COX-1 and COX-2 expression in Kaposi’s sarcoma tissues
Open Access
- 1 May 2007
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 43 (8) , 1232-1241
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Cutaneous malignancy and human immunodeficiency virus diseaseJournal of the American Academy of Dermatology, 2006
- Spindle cells and their role in Kaposi's sarcomaThe International Journal of Biochemistry & Cell Biology, 2005
- Structural and functional differences between cyclooxygenases: Fatty acid oxygenases with a critical role in cell signalingBiochemical and Biophysical Research Communications, 2005
- Cyclooxygenase-2: How good is it as a target for cancer chemoprevention?European Journal of Cancer, 2005
- Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scarsThe Journal of Pathology, 2005
- Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavityBritish Journal of Dermatology, 2004
- Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcomaNature Genetics, 2004
- Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirusNature Genetics, 2004
- COX-2 and beyond: approaches to prostaglandin inhibition in human diseaseNature Reviews Drug Discovery, 2003
- Age-Related Effects on Atherogenesis and Scavenger Enzymes of Intracranial and Extracranial Arteries in Men Without Classic Risk Factors for Atherosclerosis Editorial CommentStroke, 2001